Home > Boards > US Listed > Biotechs > Resverlogix Corp. (RVXCF)

I think the only plan is survival.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
noretreat Member Profile
 
Followed By 121
Posts 11,801
Boards Moderated 0
Alias Born 01/06/10
160x600 placeholder
noretreat   Tuesday, 04/21/20 10:45:10 AM
Re: big orange post# 1082
Post # of 1084 
I think the only plan is survival. Apabetalone has failed two large heavily publicized trials (first one was in 2014). Not by much, but missed primary endpoints equal failure. IMO, they should sell to whoever will make an offer, if anyone comes forward. Otherwise this may go to zero. Where would the $ come from to fund another big trial?

The other related company, Zenith, still has significant value and buyout potential.

But what the heck do I know?

No Retreat ... No Surrender
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist